Company / Total Assets
ARS Pharmaceuticals, Inc. Total Assets History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$327.7M
FY2025
5-year range
$61.4M / $351.2M
FY2021-FY2025
Trend
-6.7%
vs FY2024
Sector context
#178 of 214
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s total assets of $328M is lower than 83% of companies in the Health Care sector (FY2025). Total Assets has fluctuated over the past 6 years, ranging from $61M in FY2021 to $395M in FY2020.
Based on SEC 10-K filings.
$328M in FY2025 with a 5-year CAGR of -3.7%.
Improved from $233M to $328M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- +5.2%
- 5-Year CAGR
- -3.7%
- 10-Year CAGR
- -
Sector benchmark
Bottom 17% in Health CareTop 83% of 214This company $327.7M Sector average $7.5B
▼
-95.6% below sector average
Key checks
Key Insights
- 5-year CAGR of -3.7%, indicating a declining trend.
- In FY2025, total assets decreased 6.7% year-over-year.
- Ranks #178 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $327.7M | -6.7% |
| FY2024 | $351.2M | +50.6% |
| FY2023 | $233.2M | -17.1% |
| FY2022 | $281.4M | +358.0% |
| FY2021 | $61.4M | -84.4% |
| FY2020 | $394.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026